TRUE Private Wealth Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-631
Closed -$242K 274
2021
Q3
$242K Buy
+631
New +$233K 0.04% 209
2021
Q1
Sell
-475
Closed -$49K 524
2020
Q4
$49K Buy
475
+313
+193% +$31.7K 0.01% 354
2020
Q3
$11K Buy
+162
New +$11.3K ﹤0.01% 486

Other funds holding MRNA

TRUE Private Wealth Advisors's MRNA Position: Q4 2021 in Review

TRUE Private Wealth Advisors sold out of Moderna (MRNA) in Q4 2021, closing a stake of 631 shares — an estimated $242K sold.

TRUE Private Wealth Advisors first reported a position in MRNA in Q3 2020 and held it in 3 quarters. The position peaked at $242K in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • TRUE Private Wealth Advisors reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • TRUE Private Wealth Advisors sold 631 Moderna shares in Q4 2021, an estimated $242K.
  • TRUE Private Wealth Advisors first reported a position in Moderna in Q3 2020 and held it in 3 quarters.
  • TRUE Private Wealth Advisors's Moderna position peaked at $242K in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on TRUE Private Wealth Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.